BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15223354)

  • 1. Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo[def,p]chrysene (dibenzo[a,l]pyrene) is activated in vivo via its trans-11,12-dihydrodiol.
    Platt KL; Dienes HP; Tommasone M; Luch A
    Chem Biol Interact; 2004 Jun; 148(1-2):27-36. PubMed ID: 15223354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene and fluoranthene.
    Amin S; Desai D; Dai W; Harvey RG; Hecht SS
    Carcinogenesis; 1995 Nov; 16(11):2813-7. PubMed ID: 7586203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of fjord region tetraols and their use in hepatic biotransformation studies of dihydrodiols of benzo[c]chrysene, benzo[g]chrysene and dibenzo[a,l]pyrene.
    Luch A; Platt KL; Seidel A
    Carcinogenesis; 1998 Apr; 19(4):639-48. PubMed ID: 9600349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihydrodiols in mouse skin and rat mammary gland.
    Cavalieri EL; Higginbotham S; RamaKrishna NV; Devanesan PD; Todorovic R; Rogan EG; Salmasi S
    Carcinogenesis; 1991 Oct; 12(10):1939-44. PubMed ID: 1934274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of the (+)-S,S- and (-)-R,R-enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene: stereoselectivity, DNA adduct formation, and mutagenicity in Chinese hamster V79 cells.
    Luch A; Seidel A; Glatt H; Platt KL
    Chem Res Toxicol; 1997 Oct; 10(10):1161-70. PubMed ID: 9348439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin.
    Higginbotham S; RamaKrishna NV; Johansson SL; Rogan EG; Cavalieri EL
    Carcinogenesis; 1993 May; 14(5):875-8. PubMed ID: 8504480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of tumorigenicity and of dihydrodiol formation by fluorine substitution in the angular rings of dibenzo(a,i)pyrene.
    Hecht SS; LaVoie EJ; Bedenko V; Pingaro L; Katayama S; Hoffmann D; Sardella DJ; Boger E; Lehr RE
    Cancer Res; 1981 Nov; 41(11 Pt 1):4341-5. PubMed ID: 7306963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay.
    Ralston SL; Coffing SL; Seidel A; Luch A; Platt KL; Baird WM
    Chem Res Toxicol; 1997 Jun; 10(6):687-93. PubMed ID: 9208176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and mutagenicity of the diastereomeric fjord-region 11,12-dihydrodiol 13,14-epoxides of dibenzo[a,l]pyrene.
    Luch A; Glatt H; Platt KL; Oesch F; Seidel A
    Carcinogenesis; 1994 Nov; 15(11):2507-16. PubMed ID: 7955100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorigenicity of dihydrodiols and diol-epoxides of benz[c]acridine in newborn mice.
    Chang RL; Levin W; Wood AW; Kumar S; Yagi H; Jerina DM; Lehr RE; Conney AH
    Cancer Res; 1984 Nov; 44(11):5161-4. PubMed ID: 6488176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation.
    Buters JT; Mahadevan B; Quintanilla-Martinez L; Gonzalez FJ; Greim H; Baird WM; Luch A
    Chem Res Toxicol; 2002 Sep; 15(9):1127-35. PubMed ID: 12230405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumorigenicity of nitrated derivatives of pyrene, benz[a]anthracene, chrysene and benzo[a]pyrene in the newborn mouse assay.
    Wislocki PG; Bagan ES; Lu AY; Dooley KL; Fu PP; Han-Hsu H; Beland FA; Kadlubar FF
    Carcinogenesis; 1986 Aug; 7(8):1317-22. PubMed ID: 3731386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity and mutagenicity of dibenzo[a,l]pyrene and (+/-)-dibenzo[a,l]pyrene-11,12-dihydrodiol in V79MZ cells co-expressing either hCYP1A1 or hCYP1B1 together with human glutathione-S-transferase A1.
    Kushman ME; Kabler SL; Ahmad S; Doehmer J; Morrow CS; Townsend AJ
    Mutat Res; 2007 Nov; 624(1-2):80-7. PubMed ID: 17509623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory response of mouse skin exposed to the very potent carcinogen dibenzo[a,l]pyrene: a model for tumor promotion.
    Casale GP; Higginbotham S; Johansson SL; Rogan EG; Cavalieri EL
    Fundam Appl Toxicol; 1997 Mar; 36(1):71-8. PubMed ID: 9073469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and tumor-initiating activity in mouse skin of dibenzo[a,l]pyrene syn- and anti-fjord-region diolepoxides.
    Gill HS; Kole PL; Wiley JC; Li KM; Higginbotham S; Rogan EG; Cavalieri EL
    Carcinogenesis; 1994 Nov; 15(11):2455-60. PubMed ID: 7955091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenicity of the diastereomeric benz[a]anthracene 3,4-diol-1,2-epoxides and the (+)- and (-)-enantiomers of benz[a]anthracene 3,4-dihydrodiol in newborn mice.
    Wislocki PG; Buening MK; Levin W; Lehr RE; Thakker DR; Jerina DM; Conney AH
    J Natl Cancer Inst; 1979 Jul; 63(1):201-4. PubMed ID: 286829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro metabolism of benzo[a]pyrene-7,8-dihydrodiol and dibenzo[def,p]chrysene-11,12 diol in rodent and human hepatic microsomes.
    Smith JN; Mehinagic D; Nag S; Crowell SR; Corley RA
    Toxicol Lett; 2017 Mar; 269():23-32. PubMed ID: 28119020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumorigenicity of 5-methylchrysene dihydrodiols and dihydrodiol epoxides in newborn mice and on mouse skin.
    Hecht SS; Radok L; Amin S; Huie K; Melikian AA; Hoffmann D; Pataki J; Harvey RG
    Cancer Res; 1985 Apr; 45(4):1449-52. PubMed ID: 3838497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.